Addendum:
Addendum: Sequencing of BRCA1/2-alterations using NGS-based technology: annotation as a challenge
Metrics: PDF 502 views | ?
1Dr. Senckenberg Institute of Pathology, University Hospital Frankfurt, Frankfurt am Main, Germany
2Wildlab, University Hospital MVZ GmbH, Frankfurt am Main, Germany
Published: August 30, 2023
Copyright: © 2023 Ebner et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article has an addendum: No external funding was obtained.
Original article: Oncotarget. 2022; 13:464-475. DOI: https://doi.org/10.18632/oncotarget.28213.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28483